Krispy Kreme Celebrates Vaccinated Folks with Free Donuts!
Starting August 30, until September 5, every day, this renowned doughnut chain will offer two free donuts to anyone presenting a vaccination certificate. This sweet surprise follows the US Food and Drug Administration granting the Pfizer/BioNTech Covid-19 vaccine full approval.
In March, Krispy Kreme initiated a program encouraging individuals to enjoy a daily, free donut throughout the rest of the year. They've already handed out over 2.5 million of these tasty treats as part of that deal.
Their seasonal offerings also include a special, heart-shaped donut, making it an even more delightful gift.
"We had hoped this pandemic would be close to over," shared Dave Skena, Krispy Kreme's Chief Marketing Officer, in a press release. "If you haven't been vaccinated yet, please consider getting your shot. Then, treat yourself to two fantastic donuts while showing your genuine appreciation."
Krispy Kreme announced they will continue offering the daily, free donut promotion until the year's end. To qualify, participants must present their vaccination records. Eligible individuals have received at least one dose of the Pfizer-, Moderna-, or Johnson & Johnson-vaccines.
The company went public in June, but its stock market performance can be unpredictable. Since its initial launch, the stock has dropped approximately 18%.
(Image source: Aussiedlerbote.de)
Additional Perspectives
Businesses often leverage such promotions to boost consumer engagement and contribute positively to public health initiatives.
Sources: and
Enrichment Data:
- Promotions and Initiatives:
- Vaccination Promotions: Retailers and businesses are keen to promote COVID-19 vaccinations to reboot their businesses and restore pre-pandemic normality[1].
- General Promotions: Krispy Kreme regularly offers limited-time deals or freebies for specific events or milestones, but they're not tied to COVID-19 vaccinations[1].
- FDA Approval of COVID-19 Vaccines:
- Novavax Vaccine: The Novavax COVID-19 vaccine is currently under FDA review for full licensure. The company submitted a Biologics License Application (BLA) and is awaiting a final decision, expected soon[2].
- Ocugen’s Inhaled Vaccine: Ocugen secured FDA clearance for an Investigational New Drug (IND) application for an inhaled COVID-19 vaccine, OCU500. It employs novel chimpanzee adenovirus-vectored technology and will soon kick off Phase I clinical trials[3].
These points highlight Krispy Kreme's engagement in various promotional campaigns and public health initiatives, as well as the ongoing approval process for additional COVID-19 vaccines by the FDA.
